These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39558020)

  • 41. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
    Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM
    Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.
    Gupta AA; Xue W; Harrison DJ; Hawkins DS; Dasgupta R; Wolden S; Shulkin B; Qumseya A; Routh JC; MacDonald T; Feinberg S; Crompton B; Rudzinski ER; Arnold M; Venkatramani R
    Lancet Oncol; 2024 Jul; 25(7):912-921. PubMed ID: 38936378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial.
    Liu SL; Li XY; Yang JH; Wen DX; Guo SS; Liu LT; Li YF; Luo MJ; Xie SY; Liang YJ; Sun XS; Yang ZC; Lv XF; Luo DH; Li JB; Liu Q; Wang P; Guo L; Mo HY; Sun R; Yang Q; Lan KQ; Jia GD; Li R; Zhao C; Xu RH; Chen QY; Tang LQ; Mai HQ
    Lancet Oncol; 2024 Dec; 25(12):1563-1575. PubMed ID: 39522541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma.
    Yan Y; Tu Y; Cheng Q; Zhang J; Wang E; Deng Z; Yu Y; Wang L; Liu R; Chu L; Kang L; Liu J; Li X
    J Transl Med; 2024 Nov; 22(1):1087. PubMed ID: 39614361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy and radiotherapy for advanced pancreatic cancer.
    Haggstrom L; Chan WY; Nagrial A; Chantrill LA; Sim HW; Yip D; Chin V
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD011044. PubMed ID: 39635901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes.
    Petrucci MT; Bringhen S; Entrala Cerezo C; Mendes J; Armeni P
    Hematology; 2024 Dec; 29(1):2432815. PubMed ID: 39611731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health care costs among patients with relapsed/refractory multiple myeloma treated with ixazomib or daratumumab in combination with lenalidomide and dexamethasone in the United States.
    Ailawadhi S; Cheng M; DerSarkissian M; Dabora J; Young M; Noga SJ; Pi S; Zhang M; Banatwala A; Duh MS; Cherepanov D
    J Manag Care Spec Pharm; 2024 Dec; 30(12):1431-1441. PubMed ID: 39612251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial.
    Hamilton EP; Falchook GS; Wang JS; Fu S; Oza AM; Imedio ER; Kumar S; Ottesen L; Mugundu GM; de Bruin EC; O'Connor MJ; Jones SF; Spigel DR; Li BT
    Target Oncol; 2024 Nov; 19(6):879-892. PubMed ID: 39487373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival trends using DPd vs. other triplets in early RRMM patients: a population-adjusted indirect treatment comparison.
    Anwer F; Lan T; Dolph M; Moradian H; Slaff S; Shih YH; Tang D
    Future Oncol; 2024 Nov; ():1-10. PubMed ID: 39611661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008933. PubMed ID: 23744561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Retrospective clinical study on cryopreservation-free integrated autologous hematopoietic stem cell transplantation model for newly diagnosed multiple myeloma].
    Yang X; Li CL; Chen J; Che FF; Xiao R; Li H; Huang J; Jiang T; Yang HQ; Wang H; Kuang XC; Huang XB
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):488-494. PubMed ID: 38964924
    [No Abstract]   [Full Text] [Related]  

  • 52. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
    Llovet JM; Kudo M; Merle P; Meyer T; Qin S; Ikeda M; Xu R; Edeline J; Ryoo BY; Ren Z; Masi G; Kwiatkowski M; Lim HY; Kim JH; Breder V; Kumada H; Cheng AL; Galle PR; Kaneko S; Wang A; Mody K; Dutcus C; Dubrovsky L; Siegel AB; Finn RS;
    Lancet Oncol; 2023 Dec; 24(12):1399-1410. PubMed ID: 38039993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biosimilar monoclonal antibodies for cancer treatment in adults.
    Galvao TF; Livinalli A; Lopes LC; Zimmermann IR; Silva MT
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD013539. PubMed ID: 39607013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014.
    Bahlis NJ; Samaras C; Reece D; Sebag M; Matous J; Berdeja JG; Shustik J; Schiller GJ; Ganguly S; Song K; Seet CS; Acosta-Rivera M; Bar M; Quick D; Fonseca G; Liu H; Gentili C; Singh P; Siegel D
    Clin Lymphoma Myeloma Leuk; 2024 Dec; 24(12):852-862. PubMed ID: 39237427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.
    Randon G; Lonardi S; Fassan M; Palermo F; Tamberi S; Giommoni E; Ceccon C; Di Donato S; Fornaro L; Brunetti O; De Vita F; Bittoni A; Chini C; Spallanzani A; Nappo F; Bethaz V; Strippoli A; Latiano T; Cardellino GG; Giuliani F; Morano F; Niger M; Raimondi A; Prisciandaro M; Pircher CC; Sciortino C; Marchesi S; Garattini SK; Airò G; Miceli R; Di Bartolomeo M; Pietrantonio F
    Lancet Oncol; 2024 Dec; 25(12):1539-1550. PubMed ID: 39557058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy and safety of venetoclax combined with hypomethylating agents in the treatment of 83 patients with higher-risk myelodysplastic syndromes].
    Liu L; He F; Xu Y; Li T; Li YF; Tang P; Sun L
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):277-283. PubMed ID: 38716600
    [No Abstract]   [Full Text] [Related]  

  • 57. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.
    Pasquini MC; Wallace PK; Logan B; Kaur M; Tario JD; Howard A; Zhang Y; Brunstein C; Efebera Y; Geller N; Giralt S; Hari P; Horowitz MM; Koreth J; Krishnan A; Landau H; Somlo G; Shah N; Stadtmauer E; Vogl DT; Vesole DH; McCarthy PL; Hahn T
    J Clin Oncol; 2024 Aug; 42(23):2757-2768. PubMed ID: 38701390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer.
    Leary A; Estévez-García P; Sabatier R; Ray-Coquard I; Romeo M; Barretina-Ginesta P; Gil-Martin M; Garralda E; Bosch-Barrera J; Morán T; Martin-Martorell P; Nadal E; Gascón P; Rodon J; Lizcano JM; Muñoz-Guardiola P; Fierro-Durán G; Pedrós-Gámez O; Pérez-Montoyo H; Yeste-Velasco M; Cortal M; Pérez-Campos A; Alfon J; Domenech C; Pérez-Fidalgo A; Oaknin A
    BMC Cancer; 2024 Jul; 24(1):876. PubMed ID: 39039449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Couple therapy for depression.
    Barbato A; D'Avanzo B; Parabiaghi A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD004188. PubMed ID: 29882960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.